Related Experiment Video
Updated: Jun 7, 2026

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
Published on: September 7, 2013
Mithramycin A suppresses expression of the human melanoma-associated gene ABCB8
Iwona Sachrajda1, Marcin Ratajewski
1Laboratory of Transcriptional Regulation, Institute of Medical Biology, Polish Academy of Sciences, Lodowa 106, 93-232 Lodz, Poland.
Abstract:
The role of the ABCB8 gene in human cells is poorly understood, although it has been suggested to be involved in multidrug resistance in some types of cancers (e.g., melanomas). In this study, the main mechanism of transcriptional regulation of the ABCB8 gene was characterized. EMSA and ChIP assays revealed that the transcription factor Sp1 binds to the ABCB8 core promoter region, and Sp1 consensus elements were crucial for promoter activity in a luciferase reporter gene assay. Mithramycin A, an inhibitor of Sp1 binding, downregulated the expression of ABCB8 (and other ABC genes) in a concentration-dependent manner and sensitized a melanoma cell line to doxorubicin treatment. These findings may have therapeutic applications in at least a subset of melanoma patients.
Insights
Researchers identified the Sp1 transcription factor as a key regulator of the ABCB8 gene. Inhibiting Sp1 reduced ABCB8 expression and increased melanoma cell sensitivity to chemotherapy.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- The function of the ABCB8 gene in human cells remains largely unknown.
- ABCB8 is potentially implicated in multidrug resistance observed in certain cancers, such as melanoma.
Purpose of the Study:
- To elucidate the primary mechanism of transcriptional regulation for the ABCB8 gene.
- To investigate the role of transcription factor Sp1 in controlling ABCB8 gene expression.
Main Methods:
- Electrophoretic Mobility Shift Assay (EMSA) and Chromatin Immunoprecipitation (ChIP) assays were employed.
- Luciferase reporter gene assays were used to assess promoter activity.
- Mithramycin A, an Sp1 inhibitor, was utilized to study gene expression changes.
Main Results:
- The transcription factor Sp1 was confirmed to bind to the core promoter region of the ABCB8 gene.
- Sp1 consensus elements were found to be essential for ABCB8 promoter activity.
- Mithramycin A treatment led to a dose-dependent decrease in ABCB8 and other ABC gene expression.
- The inhibition of Sp1 binding sensitized melanoma cells to doxorubicin, a chemotherapy drug.
Conclusions:
- Sp1 is a critical transcriptional regulator of the ABCB8 gene.
- Targeting Sp1 may offer a therapeutic strategy for specific melanoma patient subsets.
- Understanding ABCB8 regulation could enhance multidrug resistance treatments in cancer.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Abnormal Proliferation

